Loading...
The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer
CONTEXT: Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis in need of more effective treatment options. Published evidence indicates many ACCs express the vascular endothelial growth factor receptor (VEGFR), suggesting inhibiting vascular endothelial growth factor signaling c...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Endocrine Society
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3973787/ https://ncbi.nlm.nih.gov/pubmed/24423320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-2298 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|